Cameco vs. MP Materials: Does Uranium or Rare Earths Make a Better Stock Buy in 2026?

The article favors MP Materials over Cameco for long-term investors, citing forecasts for MP's revenue to roughly double in FY2026 and nearly double again in 2027, when analysts expect its first profit. MP generated FY2025 revenue of about $224 million (+10%) but posted an $86 million net loss, a 38% negative margin, and negative free cash flow of roughly $328 million; its upside depends on U.S. rare-earth supply-chain policy and reduced Chinese competition. Cameco delivered stronger current fundamentals, with FY2025 revenue of about $2.5 billion (+11%), net income near $421 million, a 17% net margin, and $768 million in free cash flow, but is expected to grow only at a low-single-digit rate.

Analysis

The investable distinction is not uranium versus rare earths; it is contracted cash conversion versus a subsidized/strategic manufacturing ramp. CCJ’s Westinghouse exposure adds a higher-quality aftermarket and services earnings stream that should reduce its historical dependence on spot uranium over a 6-18 month horizon. MP, by contrast, remains primarily a bet that magnet qualification, customer offtake economics, and government support convert into utilization before fixed-cost absorption becomes a larger drag.

MP’s strategic value may cap downside in a national-security scenario, but strategic importance does not itself establish attractive equity economics. Its valuation leaves little tolerance for delayed volume ramps, weaker EV production, or a decline in NdPr pricing; each would defer the path to positive EBITDA and likely trigger multiple compression well before the long-term thesis is disproven. The critical missing diligence item is the contractual structure of AAPL/GM arrangements: minimum volumes, price floors, pass-through provisions, prepayments, and penalties matter more than headline contract announcements.

Consensus is likely underweighting the possibility that China uses price rather than export restrictions to preserve share. A lower rare-earth price environment would pressure MP’s near-term gross margin while benefiting magnet-consuming OEMs such as GM and potentially AAPL’s supply chain. Conversely, a supply restriction would create an acute scarcity premium, but that upside is more likely to accrue after MP demonstrates sustained separated-product and magnet output, not merely announced capacity.

Near term, neither name has an obvious news-driven catalyst absent rare-earth pricing or policy action. Over the next 1-3 months, MP earnings should be treated as an execution checkpoint; over 6-18 months, CCJ has the cleaner path to durable estimate revisions if reactor construction, fuel-cycle contracting, and Westinghouse backlog translate into cash earnings.

Key Decisions for Investors

• Prefer a 6-12 month long CCJ / short MP pair, sized beta-neutral: CCJ offers more defensible cash-flow visibility while MP carries greater ramp and valuation risk. Reassess if MP reports sustained positive magnet gross margin, binding volume commitments with pricing protection, or materially accelerated government support.
• Do not initiate a standalone MP long solely on strategic-supply-chain rhetoric. Set an alert for verified commercial magnet shipments and quarterly operating cash-flow improvement; those data points would justify revisiting a long despite the premium revenue multiple.
• For rare-earth disruption exposure, use MP only as a tactical position following confirmed Chinese export controls or material NdPr price strength, with a 1-3 month horizon. Falsification is rapid Chinese supply release or spot-price weakness that persists through the next quarterly report.
• Monitor GM production guidance and EV inventory trends as a second-order read-through for MP demand. A material GM volume cut would weaken the utilization case before MP’s own revenue guidance necessarily reflects it; in that scenario, add to the CCJ/MP relative-value trade rather than shorting GM outright.